A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331







List of co-cited articles
905 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer susceptibility gene mutations in type I and II endometrial cancer.
Beverly Long, Jenna Lilyquist, Amy Weaver, Chunling Hu, Rohan Gnanaolivu, Kun Y Lee, Steven N Hart, Eric C Polley, Jamie N Bakkum-Gamez, Fergus J Couch,[...]. Gynecol Oncol 2019
13
7

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.
Elisabetta Kuhn, Ren-Chin Wu, Bin Guan, Gang Wu, Jinghui Zhang, Yue Wang, Lei Song, Xiguo Yuan, Lei Wei, Richard B S Roden,[...]. J Natl Cancer Inst 2012
158
1

Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma.
Yuko Sugiyama, Osamu Gotoh, Nobuyuki Fukui, Norio Tanaka, Katsuhiko Hasumi, Yutaka Takazawa, Tetsuo Noda, Seiichi Mori. Am J Pathol 2020
4
25

Recent Advances in Uterine Fibroid Etiology.
Michelle M McWilliams, Vargheese M Chennathukuzhi. Semin Reprod Med 2017
37
2

DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
Leanne de Kock, Tatjana Terzic, W Glenn McCluggage, Colin J R Stewart, Patricia Shaw, William D Foulkes, Blaise A Clarke. Am J Surg Pathol 2017
43
2

Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.
Elizabeth K Lee, Amanda N Fader, Alessandro D Santin, Joyce F Liu. Gynecol Oncol 2021
4
25

The genetic landscape of endometrial clear cell carcinomas.
Deborah F DeLair, Kathleen A Burke, Pier Selenica, Raymond S Lim, Sasinya N Scott, Sumit Middha, Abhinita S Mohanty, Donavan T Cheng, Michael F Berger, Robert A Soslow,[...]. J Pathol 2017
77
1

An integrated molecular profile of endometrioid ovarian cancer.
William E Pierson, Pamela N Peters, Matthew T Chang, Lee-May Chen, David A Quigley, Alan Ashworth, Jocelyn S Chapman. Gynecol Oncol 2020
13
7

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Ian P M Tomlinson, N Afrina Alam, Andrew J Rowan, Ella Barclay, Emma E M Jaeger, David Kelsell, Irene Leigh, Patricia Gorman, Hanan Lamlum, Shamima Rahman,[...]. Nat Genet 2002
988
1

SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
David L Kolin, Fei Dong, Michele Baltay, Neal Lindeman, Laura MacConaill, Marisa R Nucci, Christopher P Crum, Brooke E Howitt. Mod Pathol 2018
50
2

Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
Anniina Färkkilä, Ulla-Maija Haltia, Johanna Tapper, Melissa K McConechy, David G Huntsman, Markku Heikinheimo. Ann Med 2017
22
4

Molecular Genetics of Endometrial Carcinoma.
Daphne W Bell, Lora Hedrick Ellenson. Annu Rev Pathol 2019
44
2

Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
Pilar Ramos, Anthony N Karnezis, David W Craig, Aleksandar Sekulic, Megan L Russell, William P D Hendricks, Jason J Corneveaux, Michael T Barrett, Karey Shumansky, Yidong Yang,[...]. Nat Genet 2014
182
1

Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations.
Satoshi Inoue, Yasushi Hirota, Toshihide Ueno, Yamato Fukui, Emiko Yoshida, Takuo Hayashi, Shinya Kojima, Reina Takeyama, Taiki Hashimoto, Tohru Kiyono,[...]. Nat Commun 2019
22
4

Defining the molecular evolution of extrauterine high grade serous carcinoma.
James P Beirne, Darragh G McArt, Aideen Roddy, Clara McDermott, Jennifer Ferris, Niamh E Buckley, Paula Coulter, Nuala McCabe, Sharon L Eddie, Philip D Dunne,[...]. Gynecol Oncol 2019
7
14

TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
Antonio Travaglino, Antonio Raffone, Annarita Gencarelli, Antonio Mollo, Maurizio Guida, Luigi Insabato, Angela Santoro, Gian Franco Zannoni, Fulvio Zullo. Pathol Oncol Res 2020
12
8

Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes.
Siân Jones, Nicolas Stransky, Christine L McCord, Ethan Cerami, James Lagowski, Devon Kelly, Samuel V Angiuoli, Mark Sausen, Lisa Kann, Manish Shukla,[...]. Nat Commun 2014
103
1

Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Jessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, Bahar H Moussavi, Daniel Lai, Aslı D Munzur, Janine Senz, Yi Kan Wang, Sina Zareian, Ali Bashashati,[...]. J Pathol Clin Res 2021
1
100

Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Matthieu Le Gallo, Meghan L Rudd, Mary Ellen Urick, Nancy F Hansen, Suiyuan Zhang, Fred Lozy, Dennis C Sgroi, August Vidal Bel, Xavier Matias-Guiu, Russell R Broaddus,[...]. Cancer 2017
41
2

Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.
Rainer Lehtonen, Maija Kiuru, Sakari Vanharanta, Jari Sjöberg, Leena-Maija Aaltonen, Kristiina Aittomäki, Johanna Arola, Ralf Butzow, Charis Eng, Kirsti Husgafvel-Pursiainen,[...]. Am J Pathol 2004
106
1

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.
Michael S Anglesio, Yi Kan Wang, Madlen Maassen, Hugo M Horlings, Ali Bashashati, Janine Senz, Robertson Mackenzie, Diljot S Grewal, Hector Li-Chang, Anthony N Karnezis,[...]. J Natl Cancer Inst 2016
67
1

Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma.
Nathaniel L Jones, Joanne Xiu, Sandeep K Reddy, William M Burke, Ana I Tergas, Jason D Wright, June Y Hou. Gynecol Oncol 2015
15
6

Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma.
Paulette Mhawech-Fauceglia, Dan Wang, Joshua Kesterson, Susanna Syriac, Kimberly Clark, Peter J Frederick, Shashikant Lele, Song Liu. PLoS One 2011
24
4

DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
Gregory R Bean, Joshua Anderson, Ankur R Sangoi, Gregor Krings, Karuna Garg. Mod Pathol 2019
24
4

Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer.
Kazue Takahashi, Naoki Sato, Tae Sugawara, Aya Kato, Toshiharu Sato, Dai Shimizu, Daisuke Tamura, Masahiko Kito, Kenichi Makino, Hiromitsu Shirasawa,[...]. Gynecol Oncol 2017
10
10


Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Fedaa Najdawi, Ashley Crook, Jayne Maidens, Christopher McEvoy, Andrew Fellowes, Justine Pickett, Musei Ho, David Nevell, Kirsten McIlroy, Amy Sheen,[...]. Pathology 2017
23
4

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.
Kenta Masuda, Akira Hirasawa, Haruko Irie-Kunitomi, Tomoko Akahane, Arisa Ueki, Yusuke Kobayashi, Wataru Yamagami, Hiroyuki Nomura, Fumio Kataoka, Eiichiro Tominaga,[...]. Jpn J Clin Oncol 2017
4
25

Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Jaclyn C Watkins, Eric J Yang, Michael G Muto, Colleen M Feltmate, Ross S Berkowitz, Neil S Horowitz, Sapna Syngal, Matthew B Yurgelun, Anu Chittenden, Jason L Hornick,[...]. Int J Gynecol Pathol 2017
49
2

Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Virgínia Piñol, Antoni Castells, Montserrat Andreu, Sergi Castellví-Bel, Cristina Alenda, Xavier Llor, Rosa M Xicola, Francisco Rodríguez-Moranta, Artemio Payá, Rodrigo Jover,[...]. JAMA 2005
381
1

Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Maran J W Berends, Ying Wu, Rolf H Sijmons, Tineke van der Sluis, Wietske Boersmavan Ek, Marjolijn J L Ligtenberg, Neeltje J W Arts, Klaske A ten Hoor, Jan H Kleibeuker, Elisabeth G E de Vries,[...]. J Clin Oncol 2003
94
1

Duodenal carcinoma in MUTYH-associated polyposis.
M Nielsen, J W Poley, S Verhoef, M van Puijenbroek, M M Weiss, G T Burger, C J Dommering, H F A Vasen, E J Kuipers, A Wagner,[...]. J Clin Pathol 2006
38
2

Clinical implications of the colorectal cancer risk associated with MUTYH mutation.
Steven J Lubbe, Maria Chiara Di Bernardo, Ian P Chandler, Richard S Houlston. J Clin Oncol 2009
121
1


The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.
Cathrin Huth, Matthias Kloor, Anita Y Voigt, Gergana Bozukova, Christina Evers, Harald Gaspar, Mirjam Tariverdian, Peter Schirmacher, Magnus von Knebel Doeberitz, Hendrik Bläker. Mod Pathol 2012
34
2

Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Jessica Moline, Haider Mahdi, Bin Yang, Charles Biscotti, Andres A Roma, Brandie Heald, Peter G Rose, Chad Michener, Charis Eng. Gynecol Oncol 2013
75
1

Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report.
Takashi Takeda, Kouji Banno, Megumi Yanokura, Mayuka Anko, Arata Kobayashi, Asako Sera, Takayuki Takahashi, Masataka Adachi, Yusuke Kobayashi, Shigenori Hayashi,[...]. Mol Clin Oncol 2018
3
33

Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Anne M Mills, Emily A Sloan, Martha Thomas, Susan C Modesitt, Mark H Stoler, Kristen A Atkins, Christopher A Moskaluk. Am J Surg Pathol 2016
46
2

Frequency and Features of Duodenal Adenomas in Patients With MUTYH-Associated Polyposis.
Sarah-Jane Walton, Frank G J Kallenberg, Susan K Clark, Evelien Dekker, Andrew Latchford. Clin Gastroenterol Hepatol 2016
19
5

Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Karen H Lu, John O Schorge, Kerry J Rodabaugh, Molly S Daniels, Charlotte C Sun, Pamela T Soliman, Kristin G White, Rajyalakshmi Luthra, David M Gershenson, Russell R Broaddus. J Clin Oncol 2007
171
1

Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
Jenny Mas-Moya, Beth Dudley, Randall E Brand, Darcy Thull, Nathan Bahary, Marina N Nikiforova, Reetesh K Pai. Hum Pathol 2015
44
2

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Sarah E Ferguson, Melyssa Aronson, Aaron Pollett, Lua R Eiriksson, Amit M Oza, Steven Gallinger, Jordan Lerner-Ellis, Zahra Alvandi, Marcus Q Bernardini, Helen J MacKay,[...]. Cancer 2014
72
1

Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Takeshi Makabe, Eri Arai, Takuro Hirano, Nanako Ito, Yukihiro Fukamachi, Yoriko Takahashi, Akira Hirasawa, Wataru Yamagami, Nobuyuki Susumu, Daisuke Aoki,[...]. Carcinogenesis 2019
18
5



Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers.
Cecilia Egoavil, Cristina Alenda, Adela Castillejo, Artemio Paya, Gloria Peiro, Ana-Beatriz Sánchez-Heras, Maria-Isabel Castillejo, Estefanía Rojas, Víctor-Manuel Barberá, Sonia Cigüenza,[...]. PLoS One 2013
71
1

Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
Tomer Adar, Linda H Rodgers, Kristen M Shannon, Makoto Yoshida, Tianle Ma, Anthony Mattia, Gregory Y Lauwers, Anthony J Iafrate, Nicole M Hartford, Esther Oliva,[...]. Cancer 2018
37
2

Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.
Osamu Inoue, Toshio Hamatani, Nobuyuki Susumu, Wataru Yamagami, Seiji Ogawa, Takashi Takemoto, Akira Hirasawa, Kouji Banno, Naoaki Kuji, Mamoru Tanaka,[...]. Reprod Biol Endocrinol 2016
22
4


Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
Wataru Yamagami, Nobuyuki Susumu, Takeshi Makabe, Kensuke Sakai, Hiroyuki Nomura, Fumio Kataoka, Akira Hirasawa, Kouji Banno, Daisuke Aoki. J Gynecol Oncol 2018
15
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.